Dasakast 70 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Dasakast 70 mg Tablet contains dasatinib, a tyrosine kinase inhibitor. Its labelling describes it for the treatment of chronic myeloid leukemia (blood cancer), used in patients whose disease cannot be treated with other medications or who cannot take those because of side effects. It is described as blocking the action of abnormal proteins so they cannot signal cancer cells to multiply, stopping or slowing the spread and growth of cancer cells. Instructions on dosage and duration can change as treatment progresses, and the benefits can take weeks or months to be noticeable.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of chronic myeloid leukaemia (blood cancer)
- Described as used when the disease cannot be treated with other medications or those cannot be tolerated
- Also listed for pancreatic cancer, small cell and non-small cell lung cancer, liver cancer, kidney cancer, thyroid cancer, gastrointestinal stromal tumour, cancer of the colon and rectum, soft tissue sarcoma, chronic idiopathic myelofibrosis, and breast cancer
Described Dosage & Administration
- Taken following the doctor’s instructions on dosage and duration, which can change as treatment progresses
- Swallowed with water, before or after a meal, at a fixed time
- If an antacid is needed, it should be taken two hours after this medicine
- Benefits can take weeks or months; the tablet must be taken exactly as instructed to avoid serious side effects
Described Side Effects
Commonly described side effects include:
- Nausea and vomiting
- Constipation and diarrhoea
- Anaemia and low blood platelets
- Rash and itching
- Fatigue
- Infection
- Musculoskeletal (bone, muscle, or joint) pain, muscle pain, and muscle spasm
- Headache
- Pulmonary hypertension (high blood pressure in the lungs)
These are described as commonly temporary. The doctor should be informed if they persist.
Precautions
- A complete medical history and list of current medications should be shared with the healthcare team
- Not to be taken if pregnant or breastfeeding
- Driving or tasks needing focus should be avoided, as the medicine can cause dizziness
- If an antacid is needed, it should be taken two hours after this medicine
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains dasatinib and is used for the treatment of chronic myeloid leukemia, particularly where other medications cannot be used or tolerated. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as swallowed with water, before or after a meal, at a fixed time, following the doctor’s instructions; any antacid should be taken two hours after this medicine.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.